2 result(s) for Head and Neck Cancers
|PI Name||Protocol #||Title|
|Matthew Taylor||IRB00011638||A Phase 2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Advanced Head and Neck Squamous Cell Carcinoma|
|Khaled Tolba||STUDY00016230||A Double-Blind, Randomized, Two Arm Phase 2 Study of Nivolumab in Combination with Ipilimumab versus Nivolumab in combination with Ipilimumab placebo Squamous Cell Carcinoma of the Head and Neck (SCCHN)|
You may also qualify for Phase 1 Program trials.
For more information: